Draper Asset Management, LLC Crispr Therapeutics Ag Transaction History

Draper Asset Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$51.17 - $68.18 $1,023 - $1,363	-20 Reduced 0.25%	7,892 $426,000
Q1 2024 May 08, 2024	SELL	$60.67 - $89.12 $10,374 - $15,239	-171 Reduced 2.12%	7,912 $539,000
Q4 2023 Feb 12, 2024	BUY	$38.62 - $72.18 $1,390 - $2,598	36 Added 0.45%	8,083 $505,000
Q3 2023 Nov 02, 2023	SELL	$45.39 - $59.0 $3,449 - $4,484	-76 Reduced 0.94%	8,047 $365,000
Q2 2023 Aug 02, 2023	SELL	$43.47 - $67.77 $9,606 - $14,977	-221 Reduced 2.65%	8,123 $456,000
Q1 2023 May 05, 2023	SELL	$41.0 - $56.12 $103,402 - $141,534	-2,522 Reduced 23.21%	8,344 $377,000
Q4 2022 Feb 08, 2023	BUY	$39.19 - $65.67 $31,273 - $52,404	798 Added 7.93%	10,866 $441,000
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $48,941 - $67,107	801 Added 8.64%	10,068 $658,000
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $45,650 - $77,964	1,056 Added 12.86%	9,267 $563,000
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $63,934 - $95,246	1,202 Added 17.15%	8,211 $515,000
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $91,677 - $145,567	1,308 Added 22.94%	7,009 $531,000
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $100,282 - $142,542	910 Added 18.99%	5,701 $638,000
Q2 2021 Aug 10, 2021	BUY	$100.84 - $161.89 $110,318 - $177,107	1,094 Added 29.59%	4,791 $776,000
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $214,464 - $406,847	1,937 Added 110.06%	3,697 $450,000
Q4 2020 Mar 03, 2021	BUY	$79.67 - $173.23 $140,219 - $304,884	1,760 New	1,760 $269,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Draper Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Draper Asset Management, LLC with notifications on news.